This retrospective review examines how optical biometry measurements are influenced by epithelial basement membrane dystrophy and Salzmann nodular degeneration. Source: AAO
This retrospective study assessed the relationship between serious immune-related adverse events during anti-PD-1 cancer therapy and tumor mutational burden. Source: AAO
This phase 2 study reports the safety and efficacy of faricimab for diabetic macular edema (DME). Source: AAO
Investigators identified patient characteristics associated with follow-up compliance after cataract surgery. Source: AAO
Investigators assessed the safety and efficacy of Schlemm canal stenting in combination with cataract surgery in eyes with mild to moderate primary open-angle glaucoma (POAG). Source: AAO
Novartis’ brolucizumab (Beovu) is now FDA approved for the treatment of wet AMD, the company reported today. Source: AAO
Researchers evaluated pharmacologic treatment options for visual snow and reported the prevalence of comorbid diseases. Source: AAO
Investigators report the long-term results of accelerated corneal collagen crosslinking (CXL) treatment in adolescent patients with progressive keratoconus. Source: AAO
This week, a classic card game gets a Braille makeover, researchers call for additional chocolate to confirm its visual benefits and Novartis partners with Microsoft on AI for macular degeneration. Source: AAO
This systematic review describes the efficacy of conventional and biologic disease-modifying antirheumatic drugs in IgG4-related orbital disease. Source: AAO